PCVX
Vaxcyte, Inc.
$53.01
+2.97%
2026-05-08
About Vaxcyte, Inc.
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Key Fundamentals
Forward P/E
-7.06
EPS (TTM)
$-6.89
ROE
-30.6%
Profit Margin
0.0%
Debt/Equity
3.88
Price/Book
2.54
Beta
1.34
Market Cap
$7.51B
Avg Volume (10D)
1.7M
Recent Breakout Signals
No recent breakout signals detected for PCVX.
Recent Price Range (60 Days)
60D High
$64.79
60D Low
$48.54
Avg Volume
1.3M
Latest Close
$53.01
Get breakout alerts for PCVX
Sign up for Breakout Scanner to receive daily notifications when PCVX triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Vaxcyte, Inc. (PCVX) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors PCVX daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. PCVX operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.